Left ventricular (LV) @entity715 can be found in @entity1 with @entity583 ( @entity583 ). No wide multicenter trial on @entity583 has provided information about LV @entity715 until now. The protocol of the GISSI-3 study included the search for the presence of LV @entity715 in @entity1 from 200 coronary care units that did not specifically focus on LV @entity715 . We examined the GISSI-3 database results related to 8,326 @entity1 at low to medium risk for LV thrombi in which a predischarge echocardiogram (9 +/- 5 days) was available. LV @entity715 was found in 427 @entity1 (5.1%): 292 of 2,544 @entity1 (11.5%) with anterior @entity583 and in 135 of 5,782 @entity1 (2.3%) with @entity583 in other sites (p <0.0001). The incidence of LV @entity715 was higher in @entity1 with ejection fraction < or = 40% (151 of 1,432 [10.5%] vs 276 of 6,894 [4%]; p <0.0001) both in the total population and in the subgroup with anterior @entity583 (106 of 597 [17.8%] vs 186 of 1,947 [9.6%]; p <0.0001). Multivariate analysis showed that only the Killip class > I and early intravenous beta-blocker administration were independently associated with higher LV @entity715 risk in the subgroup of @entity1 with anterior @entity583 (odds ratio 1.75, 95% confidence interval 1.28 to 2.39; odds ratio 1.32, 95% confidence interval 1.02 to 1.72, respectively). In @entity1 with anterior @entity583 , oral beta-blocker therapy given or not given after early intravenous beta-blocker administration does not influence the occurrence of LV @entity715 . The rate of LV @entity715 was similar in @entity1 treated or not treated with @entity3362 and @entity3593 both in the total population and in @entity1 with anterior and nonanterior @entity583 . In conclusion, in the GISSI-3 population at low to medium risk for LV thrombi, the highest rate of occurrence of LV @entity715 was found among @entity1 with anterior @entity583 and an ejection fraction < 40%. Killip class > I and the early intravenous beta-blocker administration were the only variables independently associated with a higher predischarge incidence of LV @entity715 after anterior @entity583 .

Predischarge two-dimensional echocardiographic evaluation of XXXX after @entity583 in the GISSI-3 study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity583 :: ('MESH:D009203', 'Disease') :: ['AMI', 'acute myocardial infarction'] @entity3362 :: ('MESH:D009566', 'Chemical') :: ['nitrates'] @entity3593 :: ('MESH:D017706', 'Chemical') :: ['lisinopril'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis']
@entity715 :: (MESH:D013927,Disease) :: ['left ventricular thrombosis']
